Hristo L. Svilenov

Has grant

Associate Professor

Ghent University

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hristo L. Svilenov is an Associate Professor at Ghent University, Belgium. His research focuses on protein therapeutics, with recent articles covering areas such as risk assessment of biotherapeutic transportation, molecular dynamics simulations of protein formulations, and advanced characterization techniques for antibody engineering. Additionally, he explores novel methods for stabilizing protein structures, particularly in relation to antiviral therapeutics and antibody drug development.

Recent Grants

Grant: Close

Developing novel humanized monoclonal antibodies with ultra-long CDRs inspired by nature to target the gp120 of HIV

Open Date: 2020-07-01

Close Date: 2022-07-01

Grant: Close

Testing the conformational flexiblity of human antibodies

Open Date: 2020-01-01

Close Date: 2022-01-01

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Johannes Buchner

Professor

Ludwig-Maximilians-Universität München

GERMANY

View details

Ulrike Protzer

Technical University of Munich

GERMANY

View details

Alexander Golovanov

Reader

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hristo L. Svilenov

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics

Additivity of Transfer Free Energies Enables the Description of Complex Protein Formulations in Implicit Solvent Molecular Dynamics Simulations

Understanding IgM Structure and Biology to Engineer New Antibody Therapeutics

Stability convergence in natural antibodies with ultra-long hypervariable loops

Intrinsic Differential Scanning Fluorimetry for Protein Stability Assessment in Microwell Plates

Voices in Molecular Pharmaceutics: Meet Professor Hristo Svilenov who Seeks to Improve Protein Therapeutics through Formulation and Advanced Characterization Techniques

Specific features of a scaffolding antibody light chain

Insights into the Stabilization of Interferon Alpha by Two Surfactants Revealed by STD-NMR Spectroscopy

Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

Get what you want: Identifying antibodies against pre-defined epitopes on Frizzled receptors

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

It is Never Too Late for a Cocktail - Development and Analytical Characterization of Fixed-dose Antibody Combinations

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein

Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design

Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies

Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures

Collaborators (3)

Johannes Buchner

Ulrike Protzer

Alexander Golovanov

Make your next move.